Literature DB >> 24046180

Myeloid/NK cell acute leukemia with unique blast morphology: de novo or secondary leukemia?

Shinsaku Imashuku1, Naoko Kudo, Park Sungkyu, Masaya Shinbo, Tatsuya Furukawa, Shigenori Iwae.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24046180     DOI： 10.1007/s12185-013-1441-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.

Authors:  R Suzuki; K Yamamoto; M Seto; Y Kagami; M Ogura; Y Yatabe; T Suchi; Y Kodera; Y Morishima; T Takahashi; H Saito; R Ueda; S Nakamura
Journal:  Blood       Date:  1997-09-15       Impact factor: 22.113

Review 3.  A tetraploid minimally differentiated acute myeloblastic leukemia with extensive erythrophagocytosis: a case report and literature review.

Authors:  Li Li; Jianlan Li; Guoxia Li; Yanhong Tan; Xiuhua Chen; Fanggang Ren; Haixiu Guo; Hongwei Wang
Journal:  Int J Hematol       Date:  2012-09-28       Impact factor: 2.490

Review 4.  Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.

Authors:  R Suzuki; S Nakamura
Journal:  Leuk Res       Date:  1999-07       Impact factor: 3.156

5.  Myeloid/NK cell acute leukemia.

Authors:  Bobin Chen; Xiaoping Xu; Meirong Ji; Guowei Lin
Journal:  Int J Hematol       Date:  2009-03-28       Impact factor: 2.490

6.  Risk of leukemia after platinum-based chemotherapy for ovarian cancer.

Authors:  L B Travis; E J Holowaty; K Bergfeldt; C F Lynch; B A Kohler; T Wiklund; R E Curtis; P Hall; M Andersson; E Pukkala; J Sturgeon; M Stovall
Journal:  N Engl J Med       Date:  1999-02-04       Impact factor: 91.245

7.  HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.

Authors:  A A Scott; D R Head; K J Kopecky; F R Appelbaum; K S Theil; M R Grever; I M Chen; M H Whittaker; B B Griffith; J D Licht
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

8.  Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome.

Authors:  Renuka V Iyer; Sheila N J Sait; Sei-Ichi Matsui; AnneMarie W Block; Maurice Barcos; James L Slack; Meir Wetzler; Maria R Baer
Journal:  Cancer Genet Cytogenet       Date:  2004-01-01

9.  Hemophagocytic syndrome associated with aggressive natural killer cell leukemia.

Authors:  T Okuda; S Sakamoto; T Deguchi; S Misawa; K Kashima; T Yoshihara; S Ikushima; S Hibi; S Imashuku
Journal:  Am J Hematol       Date:  1991-12       Impact factor: 10.047
  9 in total
  1 in total

1.  Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.

Authors:  Yusuke Noguchi; Daisuke Tomizawa; Haruka Hiroki; Satoshi Miyamoto; Mari Tezuka; Reiji Miyawaki; Mari Tanaka-Kubota; Tubasa Okano; Chika Kobayashi; Noriko Mitsuiki; Yuki Aoki; Kohsuke Imai; Michiko Kajiwara; Hirokazu Kanegane; Tomohiro Morio; Masatoshi Takagi
Journal:  Clin Case Rep       Date:  2018-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.